Monitoring resistance through liquid biopsy
Ann Oncol
.
2018 Jan 1;29(1):8-11.
doi: 10.1093/annonc/mdx650.
Authors
A R Parikh
1
2
,
R B Corcoran
1
2
Affiliations
1
Massachusetts General Hospital Cancer Center, Boston, USA.
2
Department of Medicine, Harvard Medical School, Boston, USA.
PMID:
29087449
PMCID:
PMC6658708
DOI:
10.1093/annonc/mdx650
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
Colorectal Neoplasms*
DNA, Neoplasm
Humans
Liquid Biopsy
Panitumumab*
Substances
DNA, Neoplasm
Panitumumab
Grants and funding
R01 CA208437/CA/NCI NIH HHS/United States
K08 CA166510/CA/NCI NIH HHS/United States